Pasar al contenido principal

DETECCION MULTIPLEXADA DE ANALITOS CON NANOPOROS

PID2020-119210RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION BIOFISICA BIZKAIA/BIOFISIKA BIZKAIA FUNDAZIOA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanopore sensing reveals a preferential pathway for the co-Translocational unfolding of a conjugative relaxase-DNA complex

  • Valenzuela-Gómez, Fernando
  • Arechaga, Ignacio
  • Rodríguez-Larrea, David
  • Cabezón, Elena
Bacterial conjugation is the main mechanism for the dissemination of antibiotic resistance genes. A single DNA strand of the conjugative plasmid is transferred across bacterial membranes covalently bound to a large multi-domain protein, named relaxase, which must be unfolded to traverse the secretion channel. Two tyrosine residues of the relaxase (Y18 and Y26 in relaxase TrwC) play an important role in the processing of conjugative DNA. We have used nanopore technology to uncover the unfolding states that take place during translocation of the relaxase–DNA complex. We observed that the relaxase unfolding pathway depends on the tyrosine residue involved in conjugative DNA binding. Transfer of the nucleoprotein complex is faster when DNA is bound to residue Y18. This is the first time in which a protein–DNA complex that is naturally translocated through bacterial membranes has been analyzed by nanopore sensing, opening new horizons to apply this technology to study protein secretion., Spanish Ministerio de Ciencia e Innovación Grants [PID2019-104251GB-I00 to E.C., PID2020-119210RB-I00 to D.R.L.]; MINECO Grant [BIO2017-88946-R to D.R.L.]; Ramon y Cajal Fellowship [RYC-2013-12799 to D.R.L.]. Funding for open access charge: Spanish Ministerio de Ciencia e Innovación Grant [PID2019-104251GB-I00]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural recognition and stabilization of tyrosine hydroxylase by the J-domain protein DNAJC12

  • Tai, Mary Dayne S.
  • Ochoa, Lissette
  • Flydal, Marte I.
  • Velasco-Carneros, Lorea
  • Muntaner, Jimena
  • Santiago, César
  • Gamiz-Arco, Gloria
  • Moro, Fernando
  • Jung-Kc, Kunwar
  • Gil-Cantero, David
  • Marcilla, Miguel
  • Kallio, Juha P.
  • Muga, Arturo
  • Valpuesta, José M.
  • Cuéllar, Jorge
  • Martínez, Aurora
Pathogenic variants of the J-domain protein DNAJC12 cause parkinsonism, which is associated with a defective interaction of DNAJC12 with tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. In this work, we characterize the formation of the TH:DNAJC12 complex, showing that DNAJC12 binding stabilizes both TH and the variant TH-p.R202H, associated with TH deficiency. This binding delays their time-dependent aggregation in an Hsp70-independent manner, while preserving TH activity and feedback regulatory inhibition by dopamine. DNAJC12 alone barely activates Hsc70 but synergistically stimulates Hsc70 ATPase activity when complexed with TH. Cryo-electron microscopy supported by crosslinking-mass spectroscopy reveals two DNAJC12 monomers bound per TH tetramer, each embracing one of the two regulatory domain dimers, leaving the active sites available for substrate, cofactor and inhibitory dopamine interaction. Our results also reveal the key role of the C-terminal region of DNAJC12 in TH binding, explaining the pathogenic mechanism of the DNAJC12 disease variant p.W175Ter., We acknowledge the support of the Spanish State Research Agency through grants PID2022-137175NB-I00 (AEI/FEDER, UE) and AEI/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (CEX2023-001386-S) to J.M.V. and J.C.; the Stiftelsen K.G. Jebsen (SKJ-MED-02; Center for Research in Parkinson’s Disease), The Neuro-SysMed Center (Research Council of Norway (RCN), Project No. 288164) and Fundació la Marató de TV3 (202012-31) to Au.M and K.J.-KC, and the Meltzer Research Fund (Project 103578) to M.D.S.T. This research was supported by grants PID2020-119210RB-I00 (MICIU/AEI/10.13039/501100011033) and IT1745-22 (Basque Government) to Ar.M. and F.M. We also acknowledge the Biophysics, Structural Biology and Screening (BiSS) core facility at the University of Bergen (UiB) and funding from NOR-OPENSCREEN (RCN, Grant No. 245922; and expert help from Dr. Svein I. Støve, Trond-André Kråkenes and Gro Haugseng). The authors acknowledge the support of the European Union (EU) and Horizon 2020 through Instruct Proposal PID 20290 and the CRIOMECORR project (ESFRI-2019-01-CSIC-16) to the cryoEM CNB-CSIC facility., With funding from the Spanish goverment through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001386-S), Peer reviewed